litlas
ログインアカウント作成

Mingzhao Xing

1997–2025 年に発表

82
論文数
19,872
被引用数
68
h 指数
79
i10 指数

被引用数

Mingzhao Xing の年別被引用数1998 年: 被引用 5 件1999 年: 被引用 1 件2000 年: 被引用 12 件2001 年: 被引用 7 件2002 年: 被引用 2 件2003 年: 被引用 11 件2004 年: 被引用 41 件2005 年: 被引用 89 件2006 年: 被引用 138 件2007 年: 被引用 139 件2008 年: 被引用 140 件2009 年: 被引用 157 件2010 年: 被引用 122 件2011 年: 被引用 180 件2012 年: 被引用 141 件2013 年: 被引用 242 件2014 年: 被引用 225 件2015 年: 被引用 193 件2016 年: 被引用 244 件2017 年: 被引用 230 件2018 年: 被引用 115 件2019 年: 被引用 832 件2020 年: 被引用 926 件2021 年: 被引用 713 件2022 年: 被引用 394 件2023 年: 被引用 291 件2024 年: 被引用 381 件2025 年: 被引用 186 件2026 年: 被引用 1 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,176 件、この内訳の 25.9%中国: 引用元論文 756 件、この内訳の 16.6%イタリア: 引用元論文 358 件、この内訳の 7.9%韓国: 引用元論文 170 件、この内訳の 3.7%イギリス: 引用元論文 148 件、この内訳の 3.2%ドイツ: 引用元論文 147 件、この内訳の 3.2%日本: 引用元論文 141 件、この内訳の 3.1%カナダ: 引用元論文 114 件、この内訳の 2.5%フランス: 引用元論文 113 件、この内訳の 2.5%スペイン: 引用元論文 108 件、この内訳の 2.4%オーストラリア: 引用元論文 99 件、この内訳の 2.2%インド: 引用元論文 94 件、この内訳の 2.1%
0%25.9%その他 24.7%

機関

分野

  • Medicine69.7%
  • Biochemistry, Genetics and Molecular Biology26.5%
  • Computer Science0.8%
  • Immunology and Microbiology0.7%
  • Environmental Science0.6%
  • Nursing0.3%
  • その他1.4%

トピック

  • Thyroid Cancer Diagnosis and Treatment16.9%
  • Thyroid Disorders and Treatments5.1%
  • Thyroid and Parathyroid Surgery4.2%
  • Cancer-related Molecular Pathways3.2%
  • BRCA gene mutations in cancer2.4%
  • COVID-19 Clinical Research Studies2.4%
  • その他65.8%

共著者

全論文

検索で開く
  1. Molecular pathogenesis and mechanisms of thyroid cancer

    著者: Mingzhao Xing - Nature reviews. Cancer 2013 被引用: 1,434

  2. BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence

    著者: Mingzhao Xing, Rengyun Liu, Xiaoli Liu, Avaniyapuram Kannan Murugan, Guangwu Zhu, Martha A. Zeiger, Sara I. Pai, Justin A. Bishop - Journal of Clinical Oncology 2014 被引用: 715

  3. TERT promoter mutations in thyroid cancer

    著者: Rengyun Liu, Mingzhao Xing - Endocrine Related Cancer 2016 被引用: 435

  4. Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer

    著者: Mingzhao Xing, Ali S. Alzahrani, Kathryn A. Carson, David Viola, Rossella Elisei, Běla Bendlová, Linwah Yip, Caterina Mian, Federica Vianello, R. Michael Tuttle, Eyal Robenshtok, James A. Fagin, Efisio Puxeddu, Laura Fugazzola, Agnieszka Czarniecka, Barbara Jarząb, Christine J. O’Neill, Mark Sywak, Alfred K. Lam, Garcilaso Riesco‐Eizaguirre, Pilar Santisteban, Hirotaka Nakayama, Ralph P. Tufano, Sara I. Pai, Martha A. Zeiger, William H. Westra, Douglas P. Clark, Roderick Clifton‐Bligh, David Sidransky, Paul W. Ladenson, Vlasta Sýkorová - JAMA 2013 被引用: 926

  5. Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer

    著者: Mingzhao Xing, Ali S. Alzahrani, Kathryn A. Carson, Young Kee Shong, Tae Yong Kim, David Viola, Rossella Elisei, Běla Bendlová, Linwah Yip, Caterina Mian, Federica Vianello, R. Michael Tuttle, Eyal Robenshtok, James A. Fagin, Efisio Puxeddu, Laura Fugazzola, Agnieszka Czarniecka, Barbara Jarząb, Christine J. O’Neill, Mark Sywak, Alfred K. Lam, Garcilaso Riesco‐Eizaguirre, Pilar Santisteban, Hirotaka Nakayama, Roderick Clifton‐Bligh, Giovanni Tallini, Elizabeth H. Holt, Vlasta Sýkorová - Journal of Clinical Oncology 2014 被引用: 521

  6. BRAF mutation in thyroid cancer

    著者: Mingzhao Xing - Endocrine Related Cancer 2005 被引用: 1,313

  7. BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications

    著者: Mingzhao Xing - Endocrine Reviews 2007 被引用: 989

  8. Highly prevalent TERT promoter mutations in aggressive thyroid cancers

    著者: Xiaoli Liu, Justin A. Bishop, Yuan Shan, Sara I. Pai, Dingxie Liu, Avaniyapuram Kannan Murugan, Hui Sun, Adel K. El‐Naggar, Mingzhao Xing - Endocrine Related Cancer 2013 被引用: 607

  9. Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer

    著者: Rengyun Liu, Justin A. Bishop, Guangwu Zhu, Tao Zhang, Paul W. Ladenson, Mingzhao Xing - JAMA Oncology 2016 被引用: 289

  10. Progress in molecular-based management of differentiated thyroid cancer

    著者: Mingzhao Xing, Bryan R. Haugen, Martin Schlumberger - The Lancet 2013 被引用: 572

  11. The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer

    著者: Jiajun Liu, Rengyun Liu, Xiaopei Shen, Guangwu Zhu, Biao Li, Mingzhao Xing - Journal of Nuclear Medicine 2019 被引用: 132

  12. Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer

    著者: Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing - Nature Communications 2018 被引用: 182

  13. TERTPromoter Mutations and Their Association withBRAFV600E Mutation and Aggressive Clinicopathological Characteristics of Thyroid Cancer

    著者: Xiaoli Liu, Shen Qu, Rengyun Liu, Chunjun Sheng, Xiaoguang Shi, Guangwu Zhu, Avaniyapuram Kannan Murugan, Haixia Guan, Hongyu Yu, Yangang Wang, Hui Sun, Zhongyan Shan, Weiping Teng, Mingzhao Xing - The Journal of Clinical Endocrinology & Metabolism 2014 被引用: 316

  14. BRAF Mutation Predicts a Poorer Clinical Prognosis for Papillary Thyroid Cancer

    著者: Mingzhao Xing, William H. Westra, Ralph P. Tufano, Yoram Cohen, Eli Rosenbaum, Kerry J. Rhoden, Kathryn A. Carson, Vasily Vasko, О. С. Ларін, Giovanni Tallini, Sara M. Tolaney, Elizabeth H. Holt, Pei Hui, Christopher B. Umbricht, Shehzad Basaria, Marge Ewertz, Anthony P. Tufaro, Joseph A. Califano, Matthew D. Ringel, Martha A. Zeiger, David Sidransky, Paul W. Ladenson - The Journal of Clinical Endocrinology & Metabolism 2005 被引用: 994

  15. Clinical utility of RAS mutations in thyroid cancer: a blurred picture now emerging clearer

    著者: Mingzhao Xing - BMC Medicine 2016 被引用: 107

  16. BRAF Mutation in Papillary Thyroid Cancer and Its Value in Tailoring Initial Treatment

    著者: Ralph P. Tufano, Gilberto Teixeira, Justin A. Bishop, Kathryn A. Carson, Mingzhao Xing - Medicine 2012 被引用: 306

  17. Genetic Alterations in the Phosphatidylinositol-3 Kinase/Akt Pathway in Thyroid Cancer

    著者: Mingzhao Xing - Thyroid 2010 被引用: 303

  18. Recent incidences and differential trends of thyroid cancer in the USA

    著者: Yushan Mao, Mingzhao Xing - Endocrine Related Cancer 2016 被引用: 208

  19. A Novel Role for Thyroid-Stimulating Hormone: Up-Regulation of Hepatic 3-Hydroxy-3-Methyl-Glutaryl-Coenzyme A Reductase Expression Through the Cyclic Adenosine Monophosphate/Protein Kinase A/Cyclic Adenosine Monophosphate–Responsive Element Binding Protein Pathway

    著者: Limin Tian, Yongfeng Song, Mingzhao Xing, Wei Zhang, Guang Ning, Xiaoying Li, Chunxiao Yu, Chengkong Qin, Jun Liu, Xingsong Tian, Xianglan Sun, Rui Fu, Lin Zhang, Xiujuan Zhang, Yan Lu, Jianwen Zou, Laicheng Wang, Qingbo Guan, Ling Gao, Jiajun Zhao - Hepatology 2010 被引用: 163

  20. BRAF Mutation in Papillary Thyroid Carcinoma

    著者: Yoram Cohen, Mingzhao Xing, Elizabeth Mambo, Zhihong Guo, G. Wu, Barry Trink, Uziel Beller, William H. Westra, Paul W. Ladenson, D. Sidransky - JNCI Journal of the National Cancer Institute 2003 被引用: 924

  21. Relationship Between the ABO Blood Group and the Coronavirus Disease 2019 (COVID-19) Susceptibility

    著者: Jiao Zhao, Yan Yang, Han-Ping Huang, Li Dong, Dongfeng Gu, Xiangfeng Lu, Zheng Zhang, Lei Liu, Ting Liu, Yukun Liu, Yunjiao He, Bin Sun, Meilan Wei, Guangyu Yang, Xinghuan Wang, Li Zhang, Xiaoyang Zhou, Mingzhao Xing, Peng George Wang - Clinical Infectious Diseases 2020 被引用: 572

  22. Genetic Alterations and Their Relationship in the Phosphatidylinositol 3-Kinase/Akt Pathway in Thyroid Cancer

    著者: Peng Hou, Dingxie Liu, Yuan Shan, Shuiying Hu, Kimberley Studeman, Stephen Condouris, Yangang Wang, Ariel Trink, Adel K. El‐Naggar, Giovanni Tallini, Vasily Vasko, Mingzhao Xing - Clinical Cancer Research 2007 被引用: 417

  23. Association of High Iodine Intake with the T1799A BRAF Mutation in Papillary Thyroid Cancer

    著者: Haixia Guan, Meiju Ji, Rong Bao, H.Y. Yu, Yangang Wang, Peng Hou, Yong Zhang, Zhongyan Shan, Weiping Teng, Mingzhao Xing - The Journal of Clinical Endocrinology & Metabolism 2009 被引用: 223

  24. Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer

    著者: Shuiying Hu, Dingxie Liu, Ralph P. Tufano, Kathryn A. Carson, Eli Rosenbaum, Yoram Cohen, Elizabeth H. Holt, Katja Kiseljak‐Vassiliades, Kerry J. Rhoden, Sara M. Tolaney, Stephen Condouris, Giovanni Tallini, William H. Westra, Christopher B. Umbricht, Martha A. Zeiger, Joseph A. Califano, Vasily Vasko, Mingzhao Xing - International Journal of Cancer 2006 被引用: 197